Compared at Biology Products
Compared at Biology Technology
Compared at Medicine News
Pain of Denial Compared to Physical Pain
If you never experienced the rejection of being picked last for a sports team, chances are you've experienced the pain of a broken heart or being turned down for a date. //Whatever the social snub, researchers say the pain of denial is not just in our heads. According to researchers, the brain seems to respond to the pain of hurt feelings in the same way as physical pain. To...
Home-based Treatment For Eczema More Effective Compared To Hospital Care
A home-based treatment for hand eczema is just as effective at treating the condition in hospital say researchers according to // a new study. Eczema is an inflammatory condition of the skin, which causes redness, itching and scaling. Researchers examined 158 patients with moderate to severe chronic hand eczema for more than one year. About half the patients followed a home-based program...
Slimmer not happy compared to Obese people
Study has showed that slimmer people mostly commit suicide and are unhappy
compared to obese people. It is found that depression level decreased as Body Mass Index (BMI) increased. //It is generally thought that people who are overweighed felt very depressed but the research results found reverse of it. Professor David Gunnell and his team from Bristol University compiled data from vari...
Women Portray Stronger Immune Response As Compared to Men, Study Suggests
Stronger Immune response in women could be the reason why isolated women are less vulnerable to falling ill and death as
compared to men, says a study// . The study is an eye-opener to the upcoming proof that there exist health differences in men and women and perhaps holds a clue to the reason why socially isolated men are prone to disease, as
compared to isolated women. Prev...
MDCT Compared to Digital Radiography in Orthopedic Patients
Evaluation of bone healing can be primarily dome by multi-detector computed tomography (MDCT) using high-quality 2D formatting as the primary imaging// technique, according to a study done by radiologists at the Medical University of Vienna in Vienna, Austria. Forty-three patients with histories of fractures, arthrodesis (joint fusion) or spinal fusions who'd undergone MDCT and conven...
More>>
Compared at Medicine Products
Compared at Medicine Technology
Pixantrone Combination Therapy for First-line Treatment of
Aggressive Non-Hodgkin's Lymphoma Results in Reduction in Severe
Toxicities Including Heart Damage When Compared to
Doxorubicin-based Therapy
Positive interim results prompt request for meeting with FDA SEATTLE, July 11, 2007 /PRNewswire-FirstCall/ -- CellTherapeutics, Inc. (CTI) announced today that interim results ofits phase II/III trial comparing CPOP-R, in which pixantrone issubstituted for doxorubicin in standard CHOP-R first-line treatmentof patients with aggressive non-Hodgkin's lymphoma (NHL), resultedin essentially al...
Data Demonstrated Saxagliptin Added to Metformin Improved Glycemic
Control in Subjects with Type 2 Diabetes Compared to Metformin
Alone
-- Additional Findings Reported Safety & Tolerability Profilein Subjects with Type 2 Diabetes and Healthy Subjects -- CHICAGO, June 25, 2007 /PRNewswire-FirstCall/ -- Phase III datapresented this week at the annual meeting of the American DiabetesAssociation demonstrated that saxagliptin, an inhibitor ofdipeptidyl-peptidase-4 (DPP-4) in development by Bristol-MyersSquibb Company and A...
Data Demonstrated Saxagliptin Added to Metformin Improved Glycemic
Control in Subjects with Type 2 Diabetes Compared to Metformin
Alone
Additional Findings Reported Safety & Tolerability Profilein Subjects with Type 2 Diabetes and Healthy Subjects CHICAGO, June 25 /PRNewswire-FirstCall/ -- Phase III datapresented this week at the annual meeting of the American DiabetesAssociation demonstrated that saxagliptin, an inhibitor ofdipeptidyl-peptidase-4 (DPP-4) in development by Bristol-MyersSquibb Company (NYSE: BMY...
Publication on Pixantrone Preclinical Studies Demonstrates Reduced
Cardiotoxicity Compared to Equiactive Doses of Doxorubicin and
Mitoxantrone
Interim results in a randomized phase II/III clinical trialanticipated later this year SEATTLE, June 26, 2007 /PRNewswire-FirstCall/ -- CellTherapeutics, Inc. (CTI) announced the publication of preclinicalstudies, which demonstrate that treatment with pixantrone (BBR2778) resulted in minimal or no significant cardiotoxicity, whiledoxorubicin and mitoxantrone induced significant cardiac da...
Actemra (tocilizumab) Significantly Improves Symptoms of Rheumatoid
Arthritis Compared to a Current Standard of Care
NUTLEY, N.J., June 15, 2007 /PRNewswire/ -- Results of theOption (TOcilizumab Pivotal Trial in Methotrexate InadequaterespONders) trial, the first multinational Phase III study outsideof Japan, showed that patients treated with Actemra (either 4mg/kgor 8mg/kg) plus methotrexate achieved a significant and clinicallyimportant improvement in the signs and symptoms of moderate tosevere rheum...
More>>